陸家嘴(600663.SH):2021年度淨利升7.45%至43.11億元 擬10派5.35元
格隆匯3月30日丨陸家嘴(600663.SH)公佈2021年年度報吿,公司實現2021年度營業收入138.72億元,同比下降4.16%;實現歸屬於上市公司股東的淨利潤43.11億元,同比增長7.45%;實現歸屬於上市公司股東的扣除非經常性損益的淨利潤37.06億元,同比下降3.39%;基本每股收益1.0686元。
公司按2021年度淨利潤的10%分別提取法定盈餘公積和任意盈餘公積後,以2021年末總股本4,034,197,440股為基數,按每10股向全體股東分配現金紅利人民幣5.35元(含税)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.